Utility of 18F-FDG PET/CT in the diagnosis and staging of extramammary Paget's disease. Issue 9 (September 2015)
- Record Type:
- Journal Article
- Title:
- Utility of 18F-FDG PET/CT in the diagnosis and staging of extramammary Paget's disease. Issue 9 (September 2015)
- Main Title:
- Utility of 18F-FDG PET/CT in the diagnosis and staging of extramammary Paget's disease
- Authors:
- Tian, Ying
Wu, Hu-Bing
Li, Dong-Li
Li, Hong-Sheng
Zhou, Wen-Lan
Wang, Quan-Shi - Abstract:
- Abstract : Purpose: Extramammary Paget's disease (EMPD) is rare, and limited data have been reported on the utilization of fluorine-18 fluorodeoxyglucose PET/computed tomography ( 18 F-FDG PET/CT) in this disease. The aim of this study is to evaluate the role of 18 F-FDG PET/CT in the diagnosis and staging of EMPD. Materials and methods: Whole-body 18 F-FDG PET/CT images of 10 patients with newly diagnosed or recurrent EMPD were retrospectively analyzed. The lesion with increased 18 F-FDG uptake was considered positive and was measured using the maximum standardized uptake value (SUVmax ). The results of PET/CT were compared by conventional staging examinations. Results: All malignant lesions showed increased 18 F-FDG uptake, except for some small lung metastases. Whole-body 18 F-FDG PET/CT detected all primary lesions in four newly diagnosed patients and recurrences in the primary sites in two patients. Two thick lesions showed intense uptake of 18 F-FDG (SUVmax : 14.9 and 7.5) whereas four thin lesions had only mild 18 F-FDG uptake (mean SUVmax : 3.25±0.24). A false-positive result was found in one patient with suspected primary recurrence. 18 F-FDG PET/CT also detected lymph node metastases in six patients, bone metastases in five patients, liver metastases in two patients, lung metastases in one patient, and an adrenal gland metastasis in one patient. Compared with conventional staging examinations, three of 10 patients were upstaged by PET/CT. Conclusion: 18 F-FDGAbstract : Purpose: Extramammary Paget's disease (EMPD) is rare, and limited data have been reported on the utilization of fluorine-18 fluorodeoxyglucose PET/computed tomography ( 18 F-FDG PET/CT) in this disease. The aim of this study is to evaluate the role of 18 F-FDG PET/CT in the diagnosis and staging of EMPD. Materials and methods: Whole-body 18 F-FDG PET/CT images of 10 patients with newly diagnosed or recurrent EMPD were retrospectively analyzed. The lesion with increased 18 F-FDG uptake was considered positive and was measured using the maximum standardized uptake value (SUVmax ). The results of PET/CT were compared by conventional staging examinations. Results: All malignant lesions showed increased 18 F-FDG uptake, except for some small lung metastases. Whole-body 18 F-FDG PET/CT detected all primary lesions in four newly diagnosed patients and recurrences in the primary sites in two patients. Two thick lesions showed intense uptake of 18 F-FDG (SUVmax : 14.9 and 7.5) whereas four thin lesions had only mild 18 F-FDG uptake (mean SUVmax : 3.25±0.24). A false-positive result was found in one patient with suspected primary recurrence. 18 F-FDG PET/CT also detected lymph node metastases in six patients, bone metastases in five patients, liver metastases in two patients, lung metastases in one patient, and an adrenal gland metastasis in one patient. Compared with conventional staging examinations, three of 10 patients were upstaged by PET/CT. Conclusion: 18 F-FDG PET/CT diagnosis of primary lesions in EMPD is mainly dependent on the thickness of the lesions, whereas it is more sensitive for the diagnosis of metastases. … (more)
- Is Part Of:
- Nuclear medicine communications. Volume 36:Issue 9(2015:Sep.)
- Journal:
- Nuclear medicine communications
- Issue:
- Volume 36:Issue 9(2015:Sep.)
- Issue Display:
- Volume 36, Issue 9 (2015)
- Year:
- 2015
- Volume:
- 36
- Issue:
- 9
- Issue Sort Value:
- 2015-0036-0009-0000
- Page Start:
- Page End:
- Publication Date:
- 2015-09
- Subjects:
- diagnosis -- extramammary Paget's disease -- fluorine-18 -- fluorodeoxyglucose -- PET/CT -- staging
Nuclear medicine -- Periodicals
616.07575 - Journal URLs:
- http://journals.lww.com/nuclearmedicinecomm/pages/default.aspx ↗
http://journals.lww.com/pages/default.aspx ↗
http://www.lww.com/Product/0143-3636 ↗ - DOI:
- 10.1097/MNM.0000000000000340 ↗
- Languages:
- English
- ISSNs:
- 0143-3636
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6180.923000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 5244.xml